SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004253
Filing Date
2021-11-12
Accepted
2021-11-12 08:06:56
Documents
72
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q svra-20210930.htm   iXBRL 10-Q 2403770
2 EX-31.1 svra-ex31_1.htm EX-31.1 17423
3 EX-31.2 svra-ex31_2.htm EX-31.2 17375
4 EX-32.1 svra-ex32_1.htm EX-32.1 12348
  Complete submission text file 0000950170-21-004253.txt   8776228

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT svra-20210930_def.xml EX-101.DEF 177391
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT svra-20210930.xsd EX-101.SCH 64752
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT svra-20210930_pre.xml EX-101.PRE 314450
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT svra-20210930_lab.xml EX-101.LAB 445438
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT svra-20210930_cal.xml EX-101.CAL 47594
10 EXTRACTED XBRL INSTANCE DOCUMENT svra-20210930_htm.xml XML 1783549
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 211399760
SIC: 2834 Pharmaceutical Preparations